Five lessons from biopharma companies’ data transformation journeys
A sales rep looking up a healthcare professional's (HCP) contact details finds three records, each with conflicting information. At the same time, leadership struggles to generate accurate global reports due to variations in customer data, with different HCP types and specialties across countries. This data fragmentation slows operations, increases costs, and blocks the ability to deliver AI-driven insights—challenges many biopharma companies face as they scale globally.
